After China, GlaxoSmithKline faces pressure for change

* Investors unhappy after bribery scandal, poor U.S. sales
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.